<DOC>
	<DOCNO>NCT00437099</DOCNO>
	<brief_summary>Borderline Personality Disorder ( BDP ) serious mental disorder affect 1-2 % general population , characterize severe psychosocial impairment high mortality rate due suicide . Currently , effective treatment BPD psychotherapy ( cognitive behavior therapy - CBT - ) pharmacotherapy ( often important adjunctive role , especially diminution symptom affective instability , impulsivity , psychotic-like symptom self-destructive behavior ) . Nevertheless , although several drug use patient , drug induce improvement symptom cause remission BPD . Thus , identification novel treatment need . The objective study examine efficacy Omacor® ( mixture omega-3-acid ethyl ester : eicosapentaenoic acid ( EPA ) docosahexaenoic acid ( DHA ) ) BDP patient receive CBT . Patients BDP randomly allocate three arm study : 1- CBT+placebo , 2- CBT+Omacor 1680 mg/d , 3- CBT+Omacor 3360 mg/d . Follow last 12 week . Assessment affective symptom , impulsivity aggressivity carry baseline 2 , 4 , 6 , 8 , 10 12 week .</brief_summary>
	<brief_title>Efficacy Omega-3 Fatty Acids Borderline Personality Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Personality Disorders</mesh_term>
	<mesh_term>Borderline Personality Disorder</mesh_term>
	<criteria>1 . Meet DSMIV criterion BPD assess Structured Clinical Interview DSMIV Personality Disorders ( SCIDII ) . 2 . Clinical Global Impression Severity BDP &gt; 3 . 3 . Age 18 65 year . 4 . Be able give inform consent participation . 5 . Place residency compatible assistance center . 6 . If woman , use effective contraception . 1 . Have serious medical illness . 2 . History omacor® allergy . 3 . Current diagnostic unipolar depression , bipolar disorder type I , ObsessiveCompulsive Disorder , schizophrenia psychotic disorder . 4 . DIBR &gt; 8 . 5 . Suicidal think require hospital admission . 6 . Meet DSMIV criterion alcohol , benzodiazepine , opioid psychostimulant dependence six month prior trial entry . 7 . Transaminase elevation within three time upper limit normality . 8 . Treatment stable dos antidepressant mood stabilizer less six week . 9 . Treatment stable dos antipsychotic 1 week last three month . 10 . Have receive electroconvulsive therapy six month prior trial entry . 11 . Have receive DBT last 12 month prior trial entry . 12 . Are pregnant nursing . 13 . Have participate investigational study last 6 month prior trial entry . 14 . Current treatment expectation start treatment drug may interact study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2010</verification_date>
</DOC>